Statements in which the resource exists as a subject.| Predicate | Object |
|---|
|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-4-14
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1466-4860
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
85; author reply 86
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12692528-Anemia,
pubmed-meshheading:12692528-Bone Marrow,
pubmed-meshheading:12692528-Erythropoietin,
pubmed-meshheading:12692528-Humans,
pubmed-meshheading:12692528-Injections, Intravenous,
pubmed-meshheading:12692528-Injections, Subcutaneous,
pubmed-meshheading:12692528-Iron,
pubmed-meshheading:12692528-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:12692528-Multiple Myeloma,
pubmed-meshheading:12692528-Recombinant Proteins
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Use of epoetin.
|
|
pubmed:publicationType |
Letter,
Comment
|
